Mounjaro Demonstrates Sustained Weight Loss Over 3 Years, Long-Term Study Confirms

Mounjaro Supports Long-Term Weight Management
Image credit: NurPhoto/Getty Images
A recent study presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveals that a once-weekly dose of tirzepatide (Mounjaro) can lead to significant and durable weight loss lasting up to three years in adults with overweight or obesity who do not have diabetes.
Key Findings:
- The treatment resulted in sustained weight reduction across a three-year period.
- Response to therapy varies by sex and presence of obesity-related health issues.
- Researchers identified three distinct weight loss patterns among participants.
Study Details:
The study involved 700 participants, primarily women, with an average age of 48 years, all of whom were either living with obesity or overweight and had prediabetes. Participants were grouped based on their weight loss trajectories:
- Group 1 (248 people): Steady loss (~10%), plateaued early.
- Group 2 (226 people): Rapid initial loss (~20%), plateaued later.
- Group 3 (226 people): Largest loss (~30%), longest time to plateau.
Insights into Weight Loss and Plateaus:
While weight loss plateaus are natural due to body mechanisms, most participants maintained significant weight reduction. The study highlights that even modest weight loss (5%) improves health markers, and greater losses (15%) yield more substantial benefits.
Expert Opinions:
Medical professionals acknowledge tirzepatide's effectiveness but emphasize the importance of ongoing support and patient education to sustain benefits. Variability in individual response underscores the need for personalized treatment plans.
Conclusion:
The findings support the use of tirzepatide as a long-term weight management tool and indicate that personalized strategies could enhance outcomes. Safety profile remains consistent with common side effects including nausea, diarrhea, and constipation.
For more insights, visit the European Congress on Obesity website or consult healthcare professionals familiar with this therapy.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough Immunotherapy Reverses Heart Damage from Cholesterol Accumulation
A groundbreaking immunotherapy developed by international researchers demonstrates the ability to reverse mitochondrial damage caused by cholesterol buildup in the heart, opening new possibilities for cardiovascular treatment. source: https://medicalxpress.com/news/2025-05-experimental-immunotherapy-reverses-heart-energy.html
US Sees Slight Increase in Measles Cases as New Outbreak Reported in Colorado
Recent CDC data shows a slight rise in measles cases across the U.S., with new outbreaks in Colorado and Texas highlighting the importance of vaccination and vigilance against this highly contagious virus.
Study Finds Younger Adults with Frailty at Increased Risk of Mortality and Hospitalization
New research shows that frailty in younger adults significantly increases the risk of death and emergency hospital admissions, highlighting the need for early detection and intervention across all adult ages.